Repository landing page

We are not able to resolve this OAI Identifier to the repository landing page. If you are the repository manager for this record, please head to the Dashboard and adjust the settings.

LSR of genome CNV from leukocytes to predict prostate cancer recurrence with short PSADT.

Abstract

<p>LSR derived from leukocyte genome CNV predicts PSADT 4 months or less. ROC analysis using LSRs derived from leukocyte CNVs as a prediction parameter (red) to predict PSADT 4 months or less, versus Nomogram (blue), Gleason’s grade (green) and the status of 8 fusion transcripts[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0135982#pone.0135982.ref014" target="_blank">14</a>] (yellow). Samples were analyzed by the same procedure as <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0135982#pone.0135982.g003" target="_blank">Fig 3</a>. (B) Combination of LSR (L), Gleason’s grade (G), Nomogram (N) and the status of fusion transcripts (F) to predict prostate cancer recurrent PSADT 4 months or less. ROC analysis of a model combining LSR, fusion transcripts, Nomogram and Gleason’s grade using LDA is indicated by black. ROC analysis of a model combining fusion transcripts, Nomogram and Gleason’s grade using LDA is indicated by red. ROC analysis of a model combining LSR, fusion transcripts and Gleason’s grade using LDA is indicated by blue. ROC analysis of a model combining LSR, fusion transcripts and Nomogram using LDA is indicated by green. ROC analysis of a model combining LSR, Nomogram and Gleason’s grade is indicated by yellow.</p

Similar works

Full text

thumbnail-image

The Francis Crick Institute

redirect
Last time updated on 12/02/2018

This paper was published in The Francis Crick Institute.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.